Bibliographic Info
GuidelineWHO guidelines for malaria, 25 November 2022.
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended against
Conditional
Certainty of evidence
Very low
Short-course standard high-dose primaquine treatment: To prevent relapse, WHO recommends against an additional treatment option of using primaquine 1.0 mg/kg/ day for seven days to treat P. vivax or P. ovale malaria.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO Guidelines for malaria, 14 March 2023
Year2023
InstitutionWHO